Medidata establishes Academic Site Advisory Board for clinical trials

Medidata has announced the formation of its Academic Site Advisory Board to advance collaboration to enhance the progress of clinical trials. The programme aims to resolve workflow obstacles, provide financial transparency, and optimise clinical trial conduct. The board’s launch expands Medidata’s Sites Insights Program, a 2025 initiative addressing challenges at trial sites. Credit: Gorodenkoff / Shutterstock.com. Dassault Systèmes brand Medidata has announced the formation of its Academic Site Advisory Board to address the distinct operational and technical hurdles faced by academic medical centres (AMCs), advancing collaboration to enhance clinical trial progress. The announcement took place at the Association of American…

Source: Clinical Trials Arena